Target intelligence / Profile preview

Pyruvate Dehydrogenase E1 Component

Molecular classification
Enzyme, Subunit, Pyruvate Dehydrogenase Complex Component
01

Overview

The pyruvate dehydrogenase E1 component is a key enzyme within the pyruvate dehydrogenase complex (PDC), which catalyzes the oxidative decarboxylation of pyruvate to acetyl-CoA and CO₂. This reaction is crucial for linking glycolysis to the citric acid (Krebs) cycle, enabling cells to convert carbohydrates into usable energy in the form of ATP. The E1 enzyme is a heterotetramer composed of two alpha (α) and two beta (β) subunits. The primary function of E1 is to catalyze the decarboxylation of pyruvate to produce CO₂ and a hydroxyethyl intermediate bound to thiamine diphosphate (ThDP/TPP), and the transfer of this hydroxyethyl group from ThDP/TPP on E1 to lipoamide on the E2 component, forming acetyl-dihydrolipoamide-E2. By converting pyruvate into acetyl-CoA, PDC enables entry into mitochondrial metabolism for ATP production. Activity can be regulated through phosphorylation/dephosphorylation mechanisms. Mutations in the gene encoding the alpha subunit (PDHA1) can cause metabolic disorders such as lactic acidosis.

02

Mechanism of action

Inhibition of enzymatic activity of E1 subunit in the pyruvate dehydrogenase complex.

03

Biological functions

Decarboxylation of pyruvateAcetyl-CoA productionLinks glycolysis with citric acid cycleMitochondrial metabolism
04

Disease associations

Metabolic disordersLactic acidosis
05

Safety considerations

Inhibition can disrupt energy metabolismPotential for lactic acidosis

Beyond the preview

Go deeper on Pyruvate Dehydrogenase E1 Component.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyruvate Dehydrogenase E1 Component.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call